Share this:
6
Europe’s market potential for cannabidiol (CBD) is pegged at around €2 billion as a treatment for chronic diseases, according to a new report by nova-Institute and HempConsult (both of Germany), who probed the market for non-psychotropic CBD, increasingly in demand as a food supplement and pharmaceutical.
Share this:
6